H. R. 1298—26
‘‘(4) GLOBAL
TUBERCULOSIS
DRUG
FACILITY.—The term
‘Global Tuberculosis Drug Facility (GDF)’ means the new initia-
tive of the Stop Tuberculosis Partnership to increase access
to high-quality tuberculosis drugs to facilitate DOTS expansion.
‘‘(5) STOP
TUBERCULOSIS
PARTNERSHIP.—The term ‘Stop
Tuberculosis Partnership’ means the partnership of the World
Health Organization, donors including the United States, high
tuberculosis burden countries, multilateral agencies, and non-
governmental and technical agencies committed to short- and
long-term measures required to control and eventually elimi-
nate tuberculosis as a public health problem in the world.’’.
(b) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—In addition to funds available under sec-
tion 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C.
2151b(c)) for such purpose or under any other provision of
that Act, there are authorized to be appropriated to the Presi-
dent, from amounts authorized to be appropriated under section
401, such sums as may be necessary for each of the fiscal
years 2004 through 2008 to carry out section 104B of the
Foreign Assistance Act of 1961, as added by subsection (a).
(2) AVAILABILITY OF FUNDS.—Amounts appropriated pursu-
ant to the authorization of appropriations under paragraph
(1) are authorized to remain available until expended.
(3) TRANSFER OF PRIOR YEAR FUNDS.—Unobligated balances
of funds made available for fiscal year 2001, 2002, or 2003
under section 104(c)(7) of the Foreign Assistance Act of 1961
(22 U.S.C. 2151b(c)(7) (as in effect immediately before the date
of enactment of this Act) shall be transferred to, merged with,
and made available for the same purposes as funds made
available for fiscal years 2004 through 2008 under paragraph
(1).
SEC. 303. ASSISTANCE TO COMBAT MALARIA.
(a) AMENDMENT OF THE FOREIGN ASSISTANCE ACT OF 1961.—
Chapter 1 of part I of the Foreign Assistance Act of 1961 (22
U.S.C. 2151 et seq.), as amended by sections 301 and 302 of this
Act, is further amended by inserting after section 104B the following
new section:
‘‘SEC. 104C. ASSISTANCE TO COMBAT MALARIA.
‘‘(a) FINDING.—Congress finds that malaria kills more people
annually than any other communicable disease except tuberculosis,
that more than 90 percent of all malaria cases are in sub-Saharan
Africa, and that children and women are particularly at risk. Con-
gress recognizes that there are cost-effective tools to decrease the
spread of malaria and that malaria is a curable disease if promptly
diagnosed and adequately treated.
‘‘(b) POLICY.—It is a major objective of the foreign assistance
program of the United States to provide assistance for the preven-
tion, control, and cure of malaria.
‘‘(c) AUTHORIZATION.—To carry out this section and consistent
with section 104(c), the President is authorized to furnish assist-
ance, on such terms and conditions as the President may determine,
for the prevention, treatment, control, and elimination of malaria.
‘‘(d) COORDINATION.—In carrying out this section, the President
shall coordinate with the World Health Organization, the Global
Fund to Fight AIDS, Tuberculosis, and Malaria, the Department
of Health and Human Services (the Centers for Disease Control
H. R. 1298—27
and Prevention and the National Institutes of Health), and other
organizations with respect to the development and implementation
of a comprehensive malaria control program.’’.
(b) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—In addition to funds available under sec-
tion 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C.
2151b(c)) for such purpose or under any other provision of
that Act, there are authorized to be appropriated to the Presi-
dent, from amounts authorized to be appropriated under section
401, such sums as may be necessary for fiscal years 2004
through 2008 to carry out section 104C of the Foreign Assist-
ance Act of 1961, as added by subsection (a), including for
the development of anti-malarial pharmaceuticals by the Medi-
cines for Malaria Venture.
(2) AVAILABILITY OF FUNDS.—Amounts appropriated pursu-
ant to paragraph (1) are authorized to remain available until
expended.
(3) TRANSFER OF PRIOR YEAR FUNDS.—Unobligated balances
of funds made available for fiscal year 2001, 2002, or 2003
under section 104(c) of the Foreign Assistance Act of 1961
(22 U.S.C. 2151b(c) (as in effect immediately before the date
of enactment of this Act) and made available for the control
of malaria shall be transferred to, merged with, and made
available for the same purposes as funds made available for
fiscal years 2004 through 2008 under paragraph (1).
(c) CONFORMING AMENDMENT.—Section 104(c) of the Foreign
Assistance Act of 1961 (22 U.S.C. 2151b(c)), as amended by section
301 of this Act, is further amended by adding after paragraph
(3) the following:
‘‘(4) RELATIONSHIP TO OTHER LAWS.—Assistance made available
under this subsection and sections 104A, 104B, and 104C, and
assistance made available under chapter 4 of part II to carry
out the purposes of this subsection and the provisions cited in
this paragraph, may be made available notwithstanding any other
provision of law that restricts assistance to foreign countries, except
for the provisions of this subsection, the provisions of law cited
in this paragraph, subsection (f), section 634A of this Act, and
provisions of law that limit assistance to organizations that support
or participate in a program of coercive abortion or involuntary
sterilization included under the Child Survival and Health Pro-
grams Fund heading in the Consolidated Appropriations Resolution,
2003 (Public Law 108–7).’’.
SEC. 304. PILOT PROGRAM FOR THE PLACEMENT OF HEALTH CARE
PROFESSIONALS 
IN 
OVERSEAS 
AREAS 
SEVERELY
AFFECTED BY HIV/AIDS, TUBERCULOSIS, AND MALARIA.
(a) IN GENERAL.—The President should establish a program
to demonstrate the feasibility of facilitating the service of United
States health care professionals in those areas of sub-Saharan
Africa and other parts of the world severely affected by HIV/AIDS,
tuberculosis, and malaria.
(b) REQUIREMENTS.—Participants in the program shall—
(1) provide basic health care services for those infected
and affected by HIV/AIDS, tuberculosis, and malaria in the
area in which they are serving;
H. R. 1298—28
(2) provide on-the-job training to medical and other per-
sonnel in the area in which they are serving to strengthen
the basic health care system of the affected countries;
(3) provide health care educational training for residents
of the area in which they are serving;
(4) serve for a period of up to 3 years; and
(5) meet the eligibility requirements in subsection (d).
(c) ELIGIBILITY REQUIREMENTS.—To be eligible to participate
in the program, a candidate shall—
(1) be a national of the United States who is a trained
health care professional and who meets the educational and
licensure requirements necessary to be such a professional such
as a physician, nurse, physician assistant, nurse practitioner,
pharmacist, other type of health care professional, or other
individual determined to be appropriate by the President; or
(2) be a retired commissioned officer of the Public Health
Service Corps.
(d) RECRUITMENT.—The President shall ensure that information
on the program is widely distributed, including the distribution
of information to schools for health professionals, hospitals, clinics,
and nongovernmental organizations working in the areas of inter-
national health and aid.
(e) PLACEMENT OF PARTICIPANTS.—
(1) IN
GENERAL.—To the maximum extent practicable,
participants in the program shall serve in the poorest areas
of the affected countries, where health care needs are likely
to be the greatest. The decision on the placement of a partici-
pant should be made in consultation with relevant officials
of the affected country at both the national and local level
as well as with local community leaders and organizations.
(2) COORDINATION.—Placement of participants in the pro-
gram shall be coordinated with the United States Agency for
International Development in countries in which that Agency
is conducting HIV/AIDS, tuberculosis, or malaria programs.
Overall coordination of placement of participants in the pro-
gram shall be made by the Coordinator of United States
Government Activities to Combat HIV/AIDS Globally (as
described in section 1(f) of the State Department Basic Authori-
ties Act of 1956 (as added by section 102(a) of this Act)).
(f) INCENTIVES.—The President may offer such incentives as
the President determines to be necessary to encourage individuals
to participate in the program, such as partial payment of principal,
interest, and related expenses on government and commercial loans
for educational expenses relating to professional health training
and, where possible, deferment of repayments on such loans, the
provision of retirement benefits that would otherwise be jeopardized
by participation in the program, and other incentives.
(g) REPORT.—Not later than 18 months after the date of enact-
ment of this Act, the President shall submit to the appropriate
congressional committees a report on steps taken to establish the
program, including—
(1) the process of recruitment, including the venues for
recruitment, the number of candidates recruited, the incentives
offered, if any, and the cost of those incentives;
(2) the process, including the criteria used, for the selection
of participants;
H. R. 1298—29
(3) the number of participants placed, the countries in
which they were placed, and why those countries were selected;
and
(4) the potential for expansion of the program.
(h) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—In addition to amounts otherwise avail-
able for such purpose, there are authorized to be appropriated
to the President, from amounts authorized to be appropriated
under section 401, such sums as may be necessary for each
of the fiscal years 2004 through 2008 to carry out the program.
(2) AVAILABILITY OF FUNDS.—Amounts appropriated pursu-
ant to the authorization of appropriations under paragraph
(1) are authorized to remain available until expended.
SEC. 305. REPORT ON TREATMENT ACTIVITIES BY RELEVANT EXECU-
TIVE BRANCH AGENCIES.
(a) IN GENERAL.—Not later than 15 months after the date
of enactment of this Act, the President shall submit to appropriate
congressional committees a report on the programs and activities
of the relevant executive branch agencies that are directed to the
treatment of individuals in foreign countries infected with HIV
or living with AIDS.
(b) REPORT ELEMENTS.—The report shall include—
(1) a description of the activities of relevant executive
branch agencies with respect to—
(A) the treatment of opportunistic infections;
(B) the use of antiretrovirals;
(C) the status of research into successful treatment
protocols for individuals in the developing world;
(D) technical assistance and training of local health
care workers (in countries affected by the pandemic) to
administer antiretrovirals, manage side effects, and mon-
itor patients’ viral loads and immune status;
(E) the status of strategies to promote sustainability
of HIV/AIDS pharmaceuticals (including antiretrovirals)
and the effects of drug resistance on HIV/AIDS patients;
and
(F) the status of appropriate law enforcement officials
working to ensure that HIV/AIDS pharmaceutical treat-
ment is not diminished through illegal counterfeiting and
black market sales of such pharmaceuticals;
(2) information on existing pilot projects, including a discus-
sion of why a given population was selected, the number of
people treated, the cost of treatment, the mechanisms estab-
lished to ensure that treatment is being administered effectively
and safely, and plans for scaling up pilot projects (including
projected timelines and required resources); and
(3) an explanation of how those activities relate to efforts
to prevent the transmission of the HIV infection.
SEC. 306. STRATEGIES TO IMPROVE INJECTION SAFETY.
Section 307 of the Public Health Service Act (42 U.S.C. 242l)
is amended by adding at the end the following:
‘‘(d) In carrying out immunization programs and other programs
in developing countries for the prevention, treatment, and control
of infectious diseases, including HIV/AIDS, tuberculosis, and